试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to characterise the safety, tolerability and efficacy of LY4170156 in subjects with advanced solid tumorsCTIS2024-511238-11-00Eli Lilly & Co.216
招募中
1 期
A Phase 1a/b study of LOXO-435 in Advanced Solid Tumor Malignancies with FGFR3 AlterationsAdvanced Solid Tumor Malignancies with FGFR3 AlterationsMedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104CTIS2022-502755-59-00Eli Lilly & Co.200
招募中
1 期
A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCERCTIS2023-508058-24-01ovImmune S.A.12
进行中（未招募）
1 期
A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCEROCALLY ADVANCED OR METASTATIC LOW TUMOR VOLUME COLORECTAL CANCERCTIS2023-508058-24-00ovImmune S.A.12
进行中（未招募）
1 期
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust MitesCTIS2022-500660-35-00Astellas Pharma Global Development Inc.28